IMMX

Immix Biopharma Inc

NASDAQ: IMMX · HEALTHCARE · BIOTECHNOLOGY

$12.50

-1.73% today

Updated 2026-09-18

Market cap

$873.50M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.88

Dividend yield

—

52W range

$2 – $15

Volume

1.6M

Market cap

$873.50M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.88

Dividend yield

—

52W range

$2 – $15

Volume

1.6M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

8.5

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

3.8

Altman Z-Score

Safe zone

—

Industry rank

—

View all highly rated stocks (75+) →252 stocks currently score above 75

Price targets

Analyst target

$21.15

+69.20%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

3 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Altman Z 3.80 — safe zone

+ Debt/equity 0.00x — low leverage

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-11.76M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$-89.52M	$0.00	$0.00	$0.00	$0.00
Net income	$-8.23M	$-15.43M	$-21.61M	$-29.44M	$-11.56M
EPS	—	—	—	—	$-0.88
Free cash flow	$-7.41M	$-11.42M	$-15.77M	$-24.66M	$-11.76M
Profit margin	9.19%	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-05-22	RACHMAN, ILYA M	Buy	500,000	—
2026-05-22	NG, CAREY	Buy	12,500	—
2026-05-22	NG, CAREY	Buy	6,250	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
IMMX	$873.50M	26	4.3	3.0	5.0	8.5	—	Avoid
LLY	$994.92B	76	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$640.02B	59	4.7	8.5	3.7	5.5	—	Buy
ABBV	$454.36B	73	6.7	8.5	4.0	5.0	-73.51%	Strong Buy
MRK	$355.10B	36	4.0	4.5	2.0	5.0	-77.20%	Hold
UNH	$340.27B	62	7.3	5.5	4.7	5.5	-15.43%	Buy

Smart narrative

Immix Biopharma Inc trades at $12.50. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 3.80, it sits in the safe zone.

Frequently asked questions

What is Immix Biopharma Inc's stock price?

Immix Biopharma Inc (IMMX) trades at $12.50.

Is Immix Biopharma Inc overvalued?

Immix Biopharma Inc carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Immix Biopharma Inc (IMMX)?

The 12-month analyst consensus target is $21.15, about 69.2% above the current $12.50. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Immix Biopharma Inc's Altman Z-Score is 3.80, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-17.44%

Beta0.20

50D MA$11.26

200D MA$8.72

Shares out0.07B

Float0.06B

Short ratio—

Avg volume1.6M

Performance

1 week+2.97%

1 month-8.49%

3 months+43.35%

YTD+139.01%

1 year+470.78%

3 years—

5 years—

Compare

IMMX vs LLY →IMMX vs JNJ →IMMX vs ABBV →Stock screener →